Advanced therapies, an opportunity to improve the quality of life of patients with different pathologies
* With the permanent intention of improving the quality and life opportunity of patients, science has worked continuously in the search for alternatives that allow offering a variety of increasingly specific, safe, and effective treatments.
* For this reason, AFIDRO hosted a webinar to discuss about “The future of treatments for patients,” where together with Juan Carlos Prieto, M.D., a doctor specializing in genetics at Javeriana University, and head of the genetics laboratory at La Victoria Hospital, more has been known about some innovations in medical topics.
Bogotá, June 2021-. As new diseases are emerging, and their characteristics are known, a door has been opened for new research spaces that have allowed the generation of new technologies and treatments. This is how several drugs, considered highly innovative and whose structure is based on genes, cells or tissues, have been developed for some time.
These drugs are part of the group known as advanced therapies, which make use of three aspects to support in the treatment of different diseases. In the first place, there is gene therapy, the main characteristic of this therapy is the use of DNA genetic material. In this case, it tries to replace a gene that is affected with a gene that works properly. According to Doctor Juan Carlos Prieto, this type of therapy is currently used for the treatment of orphan diseases and some types of cancer.
On the other hand, cell therapy, which, as its name indicates, works mainly with cells, makes use of their transformation to perform deficient functions in some system, and has been used, for example, to treat diseases such as leukemia. In addition to the two therapies already mentioned, tissue therapy also exists, in which the patient can replace an organ using other tissues and is commonly used in people who have severe skin burns.
The expert assures that in Colombia there is a great advantage because the groups of patients of different pathologies have formed associations that have made the same patients aware of their disease. Therefore, when these types of therapeutic options arrive, it would be easier to select the right candidates.
“In the country we have several Invima authorizations for recently arrived drugs, which have followed the evidence and patient safety protocols. At this point, it is key to understand that not all patients will be able to work with therapy. There are variants within diseases, and hence the importance of self-knowledge,” the expert adds.
Doctor Prieto also ensures that treating physicians, in addition to ensuring they know the expectations of patients and be able to solve their questions, must also make an observation of their needs to provide them with therapeutic options that are really convenient for them. Furthermore, he pointed out that scientific societies should be responsible for creating clear guidelines, not only for candidates for access to this type of therapy, but also for monitoring the disease and its outcome, so that treatment effectiveness can be recorded.
Finally, he indicated that patients must be responsible for their health, so it is necessary to attend recognized sites where their safety is first, and to access medicines that are supported by Invima. “Typically, on patient associations’ websites, or on those of different institutions, there information on what is under research and the therapeutic options available,” concludes the expert.
Learn more about advanced therapies on AFIDRO’s official YouTube channel, or by going to the following link: https://www.youtube.com/watch?v=X-E7q5I_zlY
Written by Afidro.